Document 0130 DOCN M95B0130 TI Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. DT 9511 AU Rottenberg ME; Riarte A; Sporrong L; Altcheh J; Petray P; Ruiz AM; Wigzell H; Orn A; Immunology Laboratory, Karolinska Institute, Stockholm, Sweden. SO Immunol Lett. 1995 Feb;45(1-2):53-60. Unique Identifier : AIDSLINE MED/95347764 AB Mice lacking CD4 and/or CD8 gene expression, generated by embryonic stem-cell technology, were used to study the role of CD4+ and CD8+ cells in the resistance to the acute infection with virulent (Tulahuen and RA) or mild (CA-I) strains of Trypanosoma cruzi. The presence of both CD4+ and CD8+ cells contributed to the survival of mice infected with T. cruzi, and each T-cell subtype was able to sustain protective functions in the absence of the other one. However, in certain host-parasite combinations, CD8+ cell-independent mechanisms were able to control the parasite load. Moreover, CD8- mice chronically infected with a low virulent strain of T. cruzi were protected from an otherwise lethal challenge with the parasite. A different organ distribution of parasite nests was observed when mutant (but not wild type) animals infected with different parasite strains were compared. CD4- mice produced high levels of IgG antibodies against peptide antigens or a whole homogenate from the parasite after infection with CA-I strain. A dramatic enhancement of IgG1- and IgG2a-specific antibodies was observed. DE Amino Acid Sequence Animal Antigens, CD4/GENETICS/*PHYSIOLOGY Antigens, CD8/GENETICS/*PHYSIOLOGY Antigens, Protozoan/*IMMUNOLOGY Chagas Disease/COMPLICATIONS/*IMMUNOLOGY CD4-Positive T-Lymphocytes/*IMMUNOLOGY CD8-Positive T-Lymphocytes/*IMMUNOLOGY H-2 Antigens/IMMUNOLOGY IgG/IMMUNOLOGY Immunologic Deficiency Syndromes/COMPLICATIONS/*IMMUNOLOGY Mice Mice, Knockout Molecular Sequence Data Support, Non-U.S. Gov't Trypanosoma cruzi/*IMMUNOLOGY/PATHOGENICITY Virulence JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).